Genetic Predisposition Clinical Trial
— COVAROfficial title:
Study of Family COsegregation of Nucleotide VARiants in the Panel of Genes to Validate Their Use in Genetic Counseling
The aim of the COVAR project is to classify reliably a maximum of VUS of the French database in order to use them for the genetic counseling. The results obtained through this study will have a major impact on clinical management of the patients and their families conducting in some cases to propose a prophylactic surgery.
Status | Recruiting |
Enrollment | 3500 |
Est. completion date | January 2, 2034 |
Est. primary completion date | January 2, 2033 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: Index cases: - A person carrying a gene variant class 3 or 4, present and selected in the families of national database of genetic group and cancer (GGC Unicancer) which identifies the variations of all genes from the panel of genes of all French laboratories. - Age = 18 years. - Signed written inform consent "index case" Related parties: - Any relative of an index case with cancer - Any relative without cancer related to an index case, retained by investigators, based on family structure and degree of related compared to the index case - Age = 18 years - Information and signature of the informed consent "selected relatives" Exclusion Criteria: - Minors - Persons deprived of liberty or under guardianship (including curators). - Absence of signed written inform consent |
Country | Name | City | State |
---|---|---|---|
France | CHU Amiens - Hôpital Nord | Amiens | |
France | ICO - Centre Paul Papin | Angers | |
France | Centre Hospitalier d'Angoulème | Angoulême | |
France | Institut Sainte-Catherine | Avignon | |
France | CHU Besançon | Besancon | |
France | Groupe Hospitalier Pellegrin | Bordeaux | |
France | Institut Bergonié | Bordeaux | |
France | Centre Hospitalier Jacques Coeur | Bourges | |
France | CHU Morvan de Brest | Brest | |
France | Centre François Baclesse | Caen | |
France | Centre Hospitalier Hôtel Dieu | Chambery | |
France | Centre Jean Perrin | Clermont-Ferrand | |
France | Hôpital Civil de Colmar | Colmar | |
France | CHU de Dijon | Dijon | |
France | CHU de Grenoble | Grenoble | |
France | Groupe Hospitalier La Rochelle-Ré-Aunis | La Rochelle | |
France | Hôpital Flaubert | Le Havre | |
France | Centre Oscar Lambret | Lille | |
France | Chru Lille | Lille | |
France | CHU Dupuytren | Limoges | |
France | Centre Léon Bérard | Lyon | |
France | Hospices Civils de Lyon | Lyon | |
France | CHU La Timone | Marseille | |
France | Institut Paoli Calmettes | Marseille | |
France | CHU Arnaud de Villeneuve | Montpellier | |
France | Centre Catherine de Sienne | Nantes | |
France | Centre Antoine Lacassagne | Nice | |
France | CHRU Caremeau | Nîmes | |
France | Centre Hospitalier Georges Renon | Niort | |
France | Hôpital de la Source | Orléans | |
France | Groupe Hospitalier Pitié-Salpêtrière | Paris | |
France | HEGP | Paris | |
France | Hôpital Saint-Antoine | Paris | |
France | Hôpital Saint-Louis | Paris | |
France | Hôpital Tenon | Paris | |
France | Institut Curie | Paris | Ile De France |
France | CHU La Milétrie | Poitiers | |
France | CHU de Reims | Reims | |
France | ICC Courlancy | Reims | |
France | Institut Jean Godinot | Reims | |
France | Centre Eugène Marquis | Rennes | |
France | CHU de Rouen | Rouen | |
France | Institut Curie - Hopital Rene Huguenin | Saint-Cloud | Haut De Seine |
France | CHU Saint Etienne | Saint-Étienne | |
France | ICO - Centre René Gauducheau | Saint-Herblain | |
France | Hopital de Hautepierre - Hôpital Universitaire | Strasbourg | |
France | Institut de Cancérologie Strasbourg Europe ICANS | Strasbourg | |
France | Institut Claudius Regaud - IUCT - Oncopole | Toulouse | |
France | CHU Bretonneau | Tours | |
France | CH Simone VEIL | Troyes | |
France | Centre Hospitalier de Valence | Valence | |
France | Centre Alexis Vautrin | Vandoeuvre les Nancy | |
France | CHU Nancy - Hôpital Brabois | Vandoeuvre les Nancy | |
France | Gustave Roussy | Villejuif | |
Guadeloupe | CHU de Pointe à Pitre | Pointe à Pitre | |
Martinique | CHU de Fort de France | Fort de France | |
Réunion | CHU Sud Réunion Saint-Pierre | Saint-Pierre |
Lead Sponsor | Collaborator |
---|---|
Institut Curie |
France, Guadeloupe, Martinique, Réunion,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Perform the co-segregation analysis of the selected VUS in the families in order to classify the maximum of variants in terms of their probability to be pathogenic | up to 15 years | ||
Secondary | • Propose a standardized method to classify VUS that can be integrated into the already existing classification established in the UMD-BRCA1/2 database, with the main focus on variants of class 4 (probably causal) and class 3 (unknown significance). | up to 15 years | ||
Secondary | • Maximize the number of VUS (both pathogenic and neutral) having associated recommendations for clinical management of at-risk relatives that can be used to guide genetic counselling. | up to 15 years | ||
Secondary | Assess the penetrance of several class 3 and 4 VUS probably associated with moderate cancer risk, using collected phenotype/genotype data on extended pedigrees. | up to 15 years |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04746794 -
Early Detection of GEnetic Risk (EDGE)
|
N/A | |
Completed |
NCT03792685 -
Looking for Personalized Nutrition for Obesity/Type 2 Diabetes Mellitus Prevention
|
N/A | |
Recruiting |
NCT04970056 -
Pancreatic Cancer Early Detection Consortium
|
||
Not yet recruiting |
NCT06441942 -
Prospective Multicenter Registry of Gender, Diversity and Inclusion (GEDI) of Women With Acute Coronary Syndrome
|
||
Terminated |
NCT04119596 -
Study of the Genome, Gut Metagenome and Diet of Patients With Incident Parkinson's Disease
|
||
Recruiting |
NCT04141462 -
EXOME Analysis Position in the Strategy of Genetic Predisposition Factors Identification in Early-onset Cancer
|
N/A | |
Completed |
NCT02826330 -
Abnormal Fecal Microbiota in Healthy Subjects at High Risk for Crohn's Disease
|
||
Recruiting |
NCT05929976 -
InterNatIonal CHildhood Leukemia Microbiome/MEtabolome Cohort
|
||
Not yet recruiting |
NCT04620278 -
Genetic Investigation of Cancer Predisposition
|
||
Active, not recruiting |
NCT02373709 -
Sequence Variations of Genes in the Estrogen Pathway and Perinatal Depression
|
||
Not yet recruiting |
NCT06089421 -
Genetic Information Assistant in Telegenetics
|
N/A | |
Completed |
NCT05975489 -
Genetics in the Effect of Caffeine on Fat Oxidation
|
N/A | |
Completed |
NCT03954652 -
Whole Genome Trio Sequencing as a Standard Routine Test in Patients With Rare Diseases - "GENOME FIRST APPROACH"
|
N/A | |
Completed |
NCT04113239 -
Study of the Genome, Gut Metagenome and Lifestyle of Patients With Incident Type 2 Diabetes Mellitus
|
||
Enrolling by invitation |
NCT04373525 -
Prospective Evaluation on Cognitive Function and Its Associated Genetic Vulnerability in Cannabis Users
|
||
Completed |
NCT03362099 -
Efficacy of the Use of Genetic Markers in the Choice of the Pharmacological Treatment of Smoking (GENTSMOKING)
|
Phase 4 | |
Recruiting |
NCT05857670 -
Psyco Quality of Life and Procreation BRCA1/2
|
||
Active, not recruiting |
NCT04774445 -
Effectiveness of MyCancerGene to Optimize Genetic Testing Outcomes
|
N/A | |
Recruiting |
NCT05759143 -
Enhancing Information Management for Young Adults After Genetic Cancer Risk Testing
|
N/A | |
Active, not recruiting |
NCT04920513 -
Universal- Versus Guidelines-Directed Genetic Testing for Germline Pathogenic Variants Utilizing a Multi-Gene Panel for Inherited Cancers in Non-Western Society.
|